KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Non-Current Debt (2016 - 2025)

Jazz Pharmaceuticals has reported Non-Current Debt over the past 15 years, most recently at $4.3 billion for Q4 2025.

  • Quarterly results put Non-Current Debt at $4.3 billion for Q4 2025, down 28.78% from a year ago — trailing twelve months through Dec 2025 was $4.3 billion (down 28.78% YoY), and the annual figure for FY2025 was $4.3 billion, down 28.78%.
  • Non-Current Debt for Q4 2025 was $4.3 billion at Jazz Pharmaceuticals, roughly flat from $4.3 billion in the prior quarter.
  • Over the last five years, Non-Current Debt for JAZZ hit a ceiling of $6.5 billion in Q2 2021 and a floor of $1.9 billion in Q1 2021.
  • Median Non-Current Debt over the past 5 years was $5.7 billion (2023), compared with a mean of $5.3 billion.
  • Biggest five-year swings in Non-Current Debt: soared 238.85% in 2021 and later dropped 28.78% in 2025.
  • Jazz Pharmaceuticals' Non-Current Debt stood at $6.0 billion in 2021, then fell by 5.41% to $5.7 billion in 2022, then dropped by 10.28% to $5.1 billion in 2023, then rose by 18.98% to $6.1 billion in 2024, then dropped by 28.78% to $4.3 billion in 2025.
  • The last three reported values for Non-Current Debt were $4.3 billion (Q4 2025), $4.3 billion (Q3 2025), and $4.3 billion (Q2 2025) per Business Quant data.